We catch you up on all the going ons in the world of rare disease. This week we report on Novartis’s ongoing campaign for Acromegly awareness, the alliance of KCNQ2 and a new soft tissue sarcoma drug called Yondelis.
Stay Connected
Sign up for updates straight to your inbox.